These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38050135)

  • 1. A Frameshift Variant of GluN2A Identified in an Epilepsy Patient Results in NMDA Receptor Mistargeting.
    Vieira MM; Peng S; Won S; Hong E; Inati SK; Thurm A; Thiam AH; Kim S; Myers SJ; Badger JD; Traynelis SF; Lu W; Roche KW
    J Neurosci; 2024 Jan; 44(4):. PubMed ID: 38050135
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
    Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
    J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Epilepsy-Associated GRIN2A Rare Variant Disrupts CaMKIIα Phosphorylation of GluN2A and NMDA Receptor Trafficking.
    Mota Vieira M; Nguyen TA; Wu K; Badger JD; Collins BM; Anggono V; Lu W; Roche KW
    Cell Rep; 2020 Sep; 32(9):108104. PubMed ID: 32877683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
    Chen X; Keramidas A; Harvey RJ; Lynch JW
    Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual NMDA receptor GluN2 subunit signaling domains differentially regulate the postnatal maturation of hippocampal excitatory synaptic transmission and plasticity but not dendritic morphology.
    Keith RE; Wild GA; Keith MJ; Chen D; Pack S; Dumas TC
    Synapse; 2024 Jul; 78(4):e22292. PubMed ID: 38813758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early expression of GluN2A-containing NMDA receptors in a model of fragile X syndrome.
    Banke TG; Traynelis SF; Barria A
    J Neurophysiol; 2024 Apr; 131(4):768-777. PubMed ID: 38380828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scribble1/AP2 complex coordinates NMDA receptor endocytic recycling.
    Piguel NH; Fievre S; Blanc JM; Carta M; Moreau MM; Moutin E; Pinheiro VL; Medina C; Ezan J; Lasvaux L; Loll F; Durand CM; Chang K; Petralia RS; Wenthold RJ; Stephenson FA; Vuillard L; Darbon H; Perroy J; Mulle C; Montcouquiol M; Racca C; Sans N
    Cell Rep; 2014 Oct; 9(2):712-27. PubMed ID: 25310985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental Changes of Synaptic and Extrasynaptic NMDA Receptor Expression in Rat Cerebellar Neurons In Vitro.
    Sibarov DA; Stepanenko YD; Silantiev IV; Abushik PA; Karelina TV; Antonov SM
    J Mol Neurosci; 2018 Feb; 64(2):300-311. PubMed ID: 29285738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
    Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
    Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of NMDA receptor trafficking and gating by activity-dependent CaMKIIα phosphorylation of the GluN2A subunit.
    Yong XLH; Zhang L; Yang L; Chen X; Tan JZA; Yu X; Chandra M; Livingstone E; Widagdo J; Vieira MM; Roche KW; Lynch JW; Keramidas A; Collins BM; Anggono V
    Cell Rep; 2021 Jul; 36(1):109338. PubMed ID: 34233182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
    Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
    Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDARs Adapt to Neurotoxic HIV Protein Tat Downstream of a GluN2A-Ubiquitin Ligase Signaling Pathway.
    Green MV; Thayer SA
    J Neurosci; 2016 Dec; 36(50):12640-12649. PubMed ID: 27810933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder.
    Pavinato L; Stanic J; Barzasi M; Gurgone A; Chiantia G; Cipriani V; Eberini I; Palazzolo L; Di Luca M; Costa A; Marcantoni A; Biamino E; Spada M; Hiatt SM; Kelley WV; Vestito L; Sisodiya SM; ; Efthymiou S; Chand P; Kaiyrzhanov R; Bruselles A; Cardaropoli S; Tartaglia M; De Rubeis S; Buxbaum JD; Smedley D; Ferrero GB; Giustetto M; Gardoni F; Brusco A
    Genet Med; 2023 Nov; 25(11):100922. PubMed ID: 37403762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Properties of Human NMDA Receptors Associated with Epilepsy-Related Mutations of GluN2A Subunit.
    Sibarov DA; Bruneau N; Antonov SM; Szepetowski P; Burnashev N; Giniatullin R
    Front Cell Neurosci; 2017; 11():155. PubMed ID: 28611597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias.
    Stanic J; Mellone M; Napolitano F; Racca C; Zianni E; Minocci D; Ghiglieri V; Thiolat ML; Li Q; Longhi A; De Rosa A; Picconi B; Bezard E; Calabresi P; Di Luca M; Usiello A; Gardoni F
    Neurobiol Dis; 2017 Dec; 108():54-64. PubMed ID: 28823933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
    Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
    PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations.
    Serraz B; Grand T; Paoletti P
    Neuropharmacology; 2016 Oct; 109():196-204. PubMed ID: 27288002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1
    Lundbye CJ; Toft AKH; Banke TG
    J Physiol; 2018 Oct; 596(20):5017-5031. PubMed ID: 30132892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glutamate receptor GluN2 subunit regulates synaptic trafficking of AMPA receptors in the neonatal mouse brain.
    Hamada S; Ogawa I; Yamasaki M; Kiyama Y; Kassai H; Watabe AM; Nakao K; Aiba A; Watanabe M; Manabe T
    Eur J Neurosci; 2014 Oct; 40(8):3136-46. PubMed ID: 25131300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.